✦ LIBER ✦

Tumor TP53 expression status, body mass index and prognosis in colorectal cancer

✍ Scribed by Teppei Morikawa; Aya Kuchiba; Xiaoyun Liao; Yu Imamura; Mai Yamauchi; Zhi Rong Qian; Reiko Nishihara; Kaori Sato; Jeffrey A. Meyerhardt; Charles S. Fuchs; Shuji Ogino

Book ID: 112101641
Publisher: John Wiley and Sons
Year: 2011
Tongue: French
Weight: 409 KB
Volume: 131
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.26495

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Body mass index (BMI) and mutations of t

Body mass index (BMI) and mutations of tumor suppressor gene p53 (TP53) in patients with urinary bladder cancer

✍ Thorsten H. Ecke; Horst H. Schlechte; Sven Gunia; Severin V. Lenk; Stefan A. Loe 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 92 KB

TP53 codon 72 polymorphism, p53 expressi

TP53 codon 72 polymorphism, p53 expression, and 1p/19q status in oligodendroglial tumors

✍ Ahmed Idbaih; Blandine Boisselier; Yannick Marie; Soufiane El Hallani; Marc Sans 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 145 KB

741 microRNA-34 expression and the statu

741 microRNA-34 expression and the status of TP53 in the primary ovarian cancer

✍ A. Swiercz; J.K. Siwicki; M. Chechlinska; M. Zajdel; A. Dansonka-Mieszkowska; A. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Expression of p53 protein in colorectal

Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis

✍ Akio Yamaguchi; Yoshiyuki Kurosaka; Sachio Fushida; Masuhiro Kanno; Yutaka Yonem 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 656 KB

Body Mass Index and Risk of Colorectal C

Body Mass Index and Risk of Colorectal Cancer in Women (United States)

✍ Jennifer Lin; Shumin M. Zhang; Nancy R. Cook; Kathryn M. Rexrode; I-Min Lee; Jul 📂 Article 📅 2004 🏛 Springer Netherlands 🌐 English ⚖ 107 KB

Immunohistochemical expression of CDX2,

Immunohistochemical expression of CDX2, β-catenin, and TP53 in inflammatory bowel disease-associated colorectal cancer

✍ Camille Laurent; Magali Svrcek; Jean-François Flejou; Marie-Pierre Chenard; Bern 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 568 KB

Background: Inflammatory bowel disease (IBD) exposes patients to an increased risk of colorectal cancer (i-CRC) and differences between i-CRC and sporadic colorectal cancer (s-CRC) pathogenesis were reported. In s-CRC, studies indicate abnormalities in the tumor-suppressor gene Cdx2. This study comp